Spinal Muscular Atrophy and COVID-19: Guidance and Resources for Providers
Advocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
NeurologyLive® Brain Games: May 25, 2025
Phase 4 Trial to Test Transition From IVIg to Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy
Bridging Bench to Bedside: Challenges in Advancing Remyelination Therapies
Positive Phase 3 Data for Oral OSA Medication AD109, FDA Clears First Blood Test for Alzheimer Disease, DHE Autoinjector Treatment Approved for Migraine